Skip to content

Total debt at other companies

Schrodinger logo
SchrodingerSDGR
$106.96M-7.9%
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
$88.58M-24.6%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$140.18M+107%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$13.61K-99.9%
ADMA Biologics logo
ADMA BiologicsADMA
$204.41M+2,055%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$3.26B+32,101%

Other financials

Income statement

See full
Revenue$215.0K-81.8%
Operating income-$30.8M-11.2%
Net income-$29.6M-12.3%
EPS (diluted)-$0.19+9.5%

Balance sheet

See full
Cash & equivalents$9.7M-84.9%
Total equity$172.0M-13.5%
Total assets$195.6M-15.9%

Cash flow

See full
Operating cash flow-$26.3M-20.5%
CapEx$30.0K+20.0%
Free cash flow-$26.3M-20.5%

Valuation

See full
Market cap$1.57B+341%
Enterprise value$1.57B+425%
P/S855.5×+782×

Profitability

See full
Operating margin-6,723%-14,525pp
Net margin-6,450.8%-13,699pp
FCF margin-5,365.2%-9,300pp

Returns & leverage

See full
Return on equity-63.9%+28.0pp
Debt / equity0.0×
Current ratio6.6×+0.9×

Where this comes from

Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $4M.

The official record: Absci Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Absci Corporation's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Absci Corporation's total debt?
Absci Corporation (ABSI) reported total debt of $4M in Q1 2026.
How has Absci Corporation's total debt changed year-over-year?
Absci Corporation's total debt decreased by 37.2% year-over-year, from $6.37M to $4M.
What is the long-term trend for Absci Corporation's total debt?
Over 5 years (2020 to 2025), Absci Corporation's total debt has grown at a -19.3% compound annual growth rate (CAGR), from $12.97M to $4.43M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.